Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice. (Q48024005)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 April 2009

Language	Label	Description	Also known as
English	Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice.	scientific article published on 9 April 2009

Statements

scholarly article

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/19359657

Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice. (English)

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/19359657

author name string

Miguel A Ortiz

1

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/19359657

Gonzalo L Campana

2

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/19359657

John R Woods

3

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/19359657

George Boguslawski

4

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/19359657

Marcelo J Sosa

5

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/19359657

Candace L Walker

6

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/19359657

Carlos A Labarrere

7

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/19359657

publication date

9 April 2009

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/19359657

Experimental Biology and Medicine

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/19359657

234

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/19359657

624-631

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/19359657

6

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/19359657

One-year cardiovascular event rates in outpatients with atherothrombosis.

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

Inflammation, atherosclerosis, and coronary artery disease

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

Inflammation and atherosclerosis: role of C-reactive protein in risk assessment

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

C-reactive protein: a critical update

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

C-reactive protein comes of age.

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

Adhesion molecules and atherogenesis

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice.

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice.

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE-/- mice

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

Varied biologic functions of C-reactive protein: lessons learned from transgenic mice.

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

C-reactive protein-bound enzymatically modified low-density lipoprotein does not transform macrophages into foam cells

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

Impaired endothelial function in C-reactive protein overexpressing mice.

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

Proapoptotic, antimigratory, antiproliferative, and antiangiogenic effects of commercial C-reactive protein on various human endothelial cell types in vitro: implications of contaminating presence of sodium azide in commercial preparation.

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

The biological effects of CRP are not attributable to endotoxin contamination: evidence from TLR4 knockdown human aortic endothelial cells

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

C-reactive protein-mediated suppression of nephrotoxic nephritis: role of macrophages, complement, and Fcgamma receptors

1 reference

https://api.crossref.org/works/10.3181%2F0812-RM-347

21 January 2018

Identifiers

10.3181/0812-RM-347

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/19359657

release_fvxxvbsrqbb4faaqdmn2qwf2lq

0 references

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/19359657

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48024005&oldid=1291272792"